COVID-19 and diabetes; Possible role of polymorphism and rise of telemedicine
• Epidemiological studies conclude diabetes to be a leading comorbidity of COVID-19. • ACE2 polymorphisms in host can influence SARS-CoV-2 susceptibility or resistance. • The in-silico data need to be corroborated with in-vivo results. • Telemedicine can bring a new change in diabetes care.
| Publié dans: | A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients. - 2016. - Amsterdam [u.a.] |
|---|---|
| Auteur principal: | |
| Format: | Article en ligne |
| Langue: | English |
| Publié: |
2021
|
| Accès à la collection: | A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients |
| Sujets: | hDPP4 CORONADO T1D SARS-CoV TEDDY DM MERS-CoV CFR COVID-19 DPP4 plus... |
| Description matérielle: | 6 |
| Accès en ligne |
Volltext |